Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen

BACKGROUND: High-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) has been investigated in patients with primary central nervous system lymphoma (PCNSL) and non-Hodgkin lymphoma (NHL) with CNS involvement and has shown promising results. PATIENTS AND METHODS: A retrospective...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Lymphoma Myeloma Leuk
Egile Nagusiak: Young, Patricia A., Gaut, Daria, Kimaiyo, Davis K., Grotts, Jonathan, Romero, Tahmineh, Chute, John, Schiller, Gary, de Vos, Sven, Eradat, Herbert A., Timmerman, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Published by Elsevier Inc. 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7138188/
https://ncbi.nlm.nih.gov/pubmed/32229199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.02.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak